Extensively drug-resistant Acinetobacter baumannii isolated in a university hospital: Role of inter-hospital transmission

Journal of Infection in Developing Countries

Volumn 10, Issue 1, 2016, Pages 96-99

  Rivera, Gonzalo ^a   Bulnes, Juan ^a   Castillo, Claudia ^a   Cristina Ajenjo, M ^a   García, Patricia ^a   Labarca, Jaime ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Inter hospital transmission

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; PENICILLIN DERIVATIVE; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DRUG RESISTANCE; GENOTYPING TECHNIQUE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LEG ULCER; MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; VIRUS TRANSMISSION; ACINETOBACTER INFECTIONS; CLASSIFICATION; DISEASE TRANSMISSION; DRUG EFFECTS; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; TRANSMISSION; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; RETROSPECTIVE STUDIES;

EID: 84956944210     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.6713     Document Type: Article

References (17)

1. Garnacho-Montero J, Amaya-Villar R (2010) Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 23: 332-339.
2. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K; EPIC II Group of Investigators (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323-2329.
3. Cifuentes DM, Silva F, García P, Bello H, Briceño I, Calvo AM, Labarca J; Grupo Colaborativo de Resistencia Bacteriana de Chile (2014) Antimicrobial susceptibility in Chile 2012. Rev Chil Infectol 31: 123-130.
4. Maragakis L, Perl T (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46: 1254-1263.
5. Barbolla RE, Centrón D, Maimone S, Rospide F, Salgueira C, Altclas J, Catalano M (2008) Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting. Am J Infect Control 36: 444-452.
6. Mezzatesta ML, D'Andrea MM, Migliavacca R, Giani T, Gona F, Nucleo E, Fugazza G, Pagani L, Rossolini GM, Stefani S (2012) Epidemiological characterization and distribution of carbapenem resistant Acinetobacter baumannii clinical isolates in Italy. Clin Microbiol Infect 18: 160-166.
7. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y (2007) Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 51: 4022-4028.
8. van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJ, Spanjaard L, Thewessen EA, van der Zee A, van Zeijl JH, Dijkshoorn L (2006) Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin Microbiol Infect 12: 837-843.
9. Marais E, De Jong G, Ferraz V, Maloba B, Dusé AG (2004) Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg, South Africa. Am J Infect Control 32: 278-281.
10. Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, Kim M (2009) Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol 30: 1186-1192.
11. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG (2005) Acinetobacter, Achromobacter, Chryseobacterium, Moraxella and other nonfermentative gram-negative rods. In Murray PR, Baron EJ, Jorgensen JH, editors. Manual of Clinical Microbiology, 8th edition. Washington: American Society for Microbiology. 749-779.
12. Clinical and Laboratory Standards Institute (2009) Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. Wayne, USA: CLSI.
13. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281.
14. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
15. Labarca JA, Salles MJ, Seas C, Guzmán-Blanco M (2014) Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America. Crit Rev Microbiol 27: 1-17.
16. van den Broek PJ, van der Reijden YKJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L (2009) Endemic and epidemic Acinetobacter species in a university hospital: an 8-year survey. J Clin Microbiol 47: 3593-3599.
17. Sader HS, Mendes CF, Pignatari AC, Pfaller MA (1996) Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Paulo, Brazil. Clin Infect Dis 23: 631-634.